About Implantable & Neural Devices
The Implantable & Neural Devices category is part of the Longevity & Human Enhancement market map, tracking 12 companies building in this segment. Senolytics, epigenetic reprogramming, exoskeletons, nootropics, and implantable devices pushing the boundaries of human lifespan and performance. Curated by Hartmann Capital's venture research team.
Companies in Implantable & Neural Devices
- Neuralink — Series F, $1.2B
- Synchron — Series D, $270M
- Blackrock Neurotech — Growth, $200M
- Precision Neuroscience — Series C, $155M
- Paradromics — Series B, $108M
- Kernel — Series A, $54M
- Cognixion — Series A, $12M
- Science Corp — Series B, $168M
- Emotiv — Series A, $10M
- OpenBCI — Series A, $6M
- Cortec Neuro — Seed, $5M
- Motif Neurotech — Series A, $19M
Frequently Asked Questions
- What companies are in the Implantable & Neural Devices category?
- The Implantable & Neural Devices category includes 12 companies: Neuralink, Synchron, Blackrock Neurotech, Precision Neuroscience, Paradromics, Kernel, Cognixion, Science Corp, Emotiv, OpenBCI, Cortec Neuro, Motif Neurotech. This is part of the Longevity & Human Enhancement market map maintained by Hartmann Capital.
- How many Implantable & Neural Devices startups are tracked?
- Hartmann Capital tracks 12 companies in the Implantable & Neural Devices segment of the Longevity & Human Enhancement market map.
- What are the best funded Implantable & Neural Devices companies?
- Top funded companies in Implantable & Neural Devices include Neuralink ($1200M), Synchron ($270M), Blackrock Neurotech ($200M), Science Corp ($168M), Precision Neuroscience ($155M). Browse the full list in the Longevity & Human Enhancement market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.